Literature DB >> 9792058

Typing methods to approach Pneumocystis carinii genetic heterogeneity.

P M Hauser1, D S Blanc, J Bille, P Francioli.   

Abstract

The study of the genetic heterogeneity of P. carinii is complicated by the lack of an in vitro culture system, as well as by the likely occurrence of co-infections with several special forms or types in a single host. Karyotyping and multilocus enzyme electrophoresis are useful for studies at the evolutionary level. However, these methods require a large number of cells, which prevents their use for the special form infecting humans. DNA sequence analysis of genomic regions is useful to study P. carinii diversity, both at the evolutionary and epidemiological levels. To type the special form specific to humans, several methods are currently used to detect polymorphism in PCR products of polymorphic regions of the genome: DNA sequencing, type-specific hybridisations, and single-strand conformation polymorphism. All these methods still need evaluation. The frequency of potential co-infections in humans determined by these various methods is different. The differences could be due to methodological problems or to real variations between patient populations, geographical locations and/or prophylaxis regimens. In the future, elucidating the population structure of P. carinii and the frequency of potential co-infections is going to be crucial for a better understanding of its epidemiology, and thus for a better prevention of P. carinii pneumonia in humans.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9792058     DOI: 10.1111/j.1574-695X.1998.tb01184.x

Source DB:  PubMed          Journal:  FEMS Immunol Med Microbiol        ISSN: 0928-8244


  13 in total

1.  Heterogeneity and compartmentalization of Pneumocystis carinii f. sp. hominis genotypes in autopsy lungs.

Authors:  J Helweg-Larsen; B Lundgren; J D Lundgren
Journal:  J Clin Microbiol       Date:  2001-10       Impact factor: 5.948

2.  Potential coinfections complicate typing of Pneumocystis carinii f. sp. hominis.

Authors:  P M Hauser; D S Blanc; A Telenti; A Nahimana; J Bille; P Francioli
Journal:  J Clin Microbiol       Date:  1998-10       Impact factor: 5.948

3.  In vitro selection and in vivo efficacy of piperazine- and alkanediamide-linked bisbenzamidines against Pneumocystis pneumonia in mice.

Authors:  Melanie T Cushion; Peter D Walzer; Alan Ashbaugh; Sandra Rebholz; Ronald Brubaker; Jean Jacques Vanden Eynde; Annie Mayence; Tien L Huang
Journal:  Antimicrob Agents Chemother       Date:  2006-07       Impact factor: 5.191

4.  Heterogeneity of Pneumocystis sterol profiles of samples from different sites in the same pair of lungs suggests coinfection by distinct organism populations.

Authors:  Z Amit; E S Kaneshiro
Journal:  J Clin Microbiol       Date:  2001-03       Impact factor: 5.948

5.  Time between inoculations and karyotype forms of Pneumocystis carinii f. sp. Carinii influence outcome of experimental coinfections in rats.

Authors:  M T Cushion; S Orr; S P Keely; J R Stringer
Journal:  Infect Immun       Date:  2001-01       Impact factor: 3.441

6.  Rapid detection of mutations in the human-derived Pneumocystis carinii dihydropteroate synthase gene associated with sulfa resistance.

Authors:  L Ma; J A Kovacs
Journal:  Antimicrob Agents Chemother       Date:  2001-03       Impact factor: 5.191

7.  Genetic diversity of Pneumocystis carinii f. sp. hominis based on variations in nucleotide sequences of internal transcribed spacers of rRNA genes.

Authors:  Laila F Nimri; Iaci N S Moura; Laurence Huang; Carlos del Rio; David Rimland; Jeffrey S Duchin; Ellen M Dotson; Charles B Beard
Journal:  J Clin Microbiol       Date:  2002-04       Impact factor: 5.948

8.  Genetic variation in Pneumocystis carinii isolates from different geographic regions: implications for transmission.

Authors:  C B Beard; J L Carter; S P Keely; L Huang; N J Pieniazek; I N Moura; J M Roberts; A W Hightower; M S Bens; A R Freeman; S Lee; J R Stringer; J S Duchin; C del Rio; D Rimland; R P Baughman; D A Levy; V J Dietz; P Simon; T R Navin
Journal:  Emerg Infect Dis       Date:  2000 May-Jun       Impact factor: 6.883

Review 9.  A new name (Pneumocystis jiroveci) for Pneumocystis from humans.

Authors:  James R Stringer; Charles B Beard; Robert F Miller; Ann E Wakefield
Journal:  Emerg Infect Dis       Date:  2002-09       Impact factor: 6.883

10.  Risk for Pneumocystis carinii transmission among patients with pneumonia: a molecular epidemiology study.

Authors:  Elodie Senggen Manoloff; Patrick Francioli; Patrick Taffé; Guy Van Melle; Jacques Bille; Philippe M Hauser
Journal:  Emerg Infect Dis       Date:  2003-01       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.